Assessment of thrombocytopenia, sleep apnea, and cardiac involvement in GNE myopathy patients.

Madoka Mori-YoshimuraAyano KimuraAyumi TsuruHiroyuki YajimaKazuhiko SegawaKatsuhiro MizunoYasushi OyaSatoru NoguchiIchizo NishinoYuji Takahashi

Published in: Muscle & nerve (2021)

PA-IgG is a potential disease biomarker in GNE myopathy patients, although its significance needs to be clarified. While none of the patients in this study experienced cardiomyopathy or arrythmia due to myopathy, sleep apnea was identified as a frequent complication.

Keyphrases

end stage renal disease
sleep apnea
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
late onset
risk assessment
left ventricular
patient reported outcomes
climate change
early onset